At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 1,060 enrolled
Drug / intervention
DEFINITY®drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CARES (Contrast EchocArdiography REgistry for Safety Surveillance): A Prospective, Phase IV, Open-Label, Nonrandomized, Multicenter, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice
In Brief
A Phase 4 clinical trial evaluating DEFINITY® for Cardiovascular Disease. Completed, enrolled 1,060 participants across 16 sites.
Detailed Summary
The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Disease
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2008
First PostedFeb 2008
Primary CompletionMay 2009
Study CompletionJul 2009
TodayJul 2026
First PostedFeb 28, 2008
Enrollment StartFeb 1, 2008
Primary CompletionMay 1, 2009
Study CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 18.3 years ago
Interventions
DEFINITY®drug
DEFINITY may be injected by either an intravenous or bolus injection or infusion. Dosage as per standard clinical practice and Package Insert